During the past decade, Severance Cardiovascular Hospital, Yonsei University Health System conducted 48 clinical trials. In the 10-year time frame, 48 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 22 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Severance Cardiovascular Hospital, Yonsei University Health System" #1 collaborator was "Chong Kun Dang Pharmaceutical Corp." with 2 trials as a collaborator, "Medtronic" with 2 trials as a collaborator, "Daiichi Sankyo Korea Co., Ltd., a Daiichi Sankyo Company" with 1 trials as a collaborator and "National Heart, Lung, and Blood Institute (NHLBI)" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Severance Cardiovascular Hospital, Yonsei University Health System" are "Atrial Fibrillation" (13 trials), "Coronary Artery Disease" (10 trials), "Paroxysmal Atrial Fibrillation" (4 trials), "Dyslipidemias" (3 trials) and "Acute Heart Failure" (2 trials). Many other conditions were trialed in "Severance Cardiovascular Hospital, Yonsei University Health System" in a lesser frequency.

Most popular intervention types in "Severance Cardiovascular Hospital, Yonsei University Health System" are "Drug" (23 trials), "Procedure" (13 trials), "Device" (8 trials), "Other" (4 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "Anticoagulation group(Apixaban group)" (2 trials), "Atorvastatin" (2 trials), "Cryoballoon Pulmonary Vein isolation" (2 trials), "Radiofrequency Pulmonary Vein isolation and Additional Right Atrial linear ablation" (2 trials) and "Amiloride" (1 trials). Other intervention names were less common.

The vast majority of trials in "Severance Cardiovascular Hospital, Yonsei University Health System" are 60 trials for "All" genders.

Currently, there are NaN active trials in "Severance Cardiovascular Hospital, Yonsei University Health System". 5 are not yet recruiting, 14 are recruiting, undefined are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 18 completed trials in Severance Cardiovascular Hospital, Yonsei University Health System, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Severance Cardiovascular Hospital, Yonsei University Health System, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 17 trials, and there were also 22 trials that are defined as “Not Applicable".